Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 44 results.
User Information
Export Records
  1. 1.   Stem-Cell-Based Tumorigenesis in Adult Drosophila
  2. Hou, Steven; Singh, Shree Ram; Pick, L
  3. FLY MODELS OF HUMAN DISEASES (Book Series: Current Topics in Developmental Biology). 2017; 121 : 311-337.
  1. 2.   A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20
  2. Blank, M.; Tang, Y.; Yamashita, M.; Burkett, S. S.; Cheng, S. Y.; Zhang, Y. E.
  3. Nature Medicine. 2012, Feb; 18(2): 227-234.
  1. 3.   MG-2477, a new tubulin inhibitor, induces autophagy through inhibition of the Akt/mTOR pathway and delayed apoptosis in A549 cells
  2. Viola, G.; Bortolozzi, R.; Hamel, E.; Moro, S.; Brun, P.; Castagliuolo, I.; Ferlin, M. G.; Basso, G.
  3. Biochemical Pharmacology. 2012, Jan; 83(1): 16-26.
  1. 4.   Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors
  2. Leese, M. P.; Jourdan, F.; Dohle, W.; Kimberley, M. R.; Thomas, M. P.; Bai, R. L.; Hamel, E.; Ferrandis, E.; Potter, B. V. L.
  3. Acs Medicinal Chemistry Letters. 2012, Jan; 3(1): 5-9.
  1. 5.   Hypoxia, stem cells and bone tumor
  2. Zeng, W.; Wan, R.; Zheng, Y. H.; Singh, S. R.; Wei, Y. Y.
  3. Cancer Letters. 2011, Dec; 313(2): 129-136.
  1. 6.   The B-Raf Status of Tumor Cells May Be a Significant Determinant of Both Antitumor and Anti-Angiogenic Effects of Pazopanib in Xenograft Tumor Models
  2. Gril, B.; Palmieri, D.; Qian, Y.; Anwar, T.; Ileva, L.; Bernardo, M.; Choyke, P.; Liewehr, D. J.; Steinberg, S. M.; Steeg, P. S.
  3. Plos One. 2011, Oct; 6(10): 11.
  1. 7.   The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling
  2. Ping, Y. F.; Yao, X. H.; Jiang, J. Y.; Zhao, L. T.; Yu, S. C.; Jiang, T.; Lin, M. C. M.; Chen, J. H.; Wang, B.; Zhang, R.; Cui, Y. H.; Qian, C.; Wang, J. M.; Bian, X. W.
  3. Journal of Pathology. 2011, Jul; 224(3): 344-354.
  1. 8.   Multiple-Targeting and Conformational Selection in the Estrogen Receptor: Computation and Experiment
  2. Yuan, P.; Liang, K. W.; Ma, B. Y.; Zheng, N.; Nussinov, R.; Huang, J.
  3. Chemical Biology & Drug Design. 2011, Jul; 78(1): 137-149.
  1. 9.   Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1 alpha Expression in an AhR-Independent Fashion
  2. Terzuoli, E.; Puppo, M.; Rapisarda, A.; Uranchimeg, B.; Cao, L. A.; Burger, A. M.; Ziche, M.; Melillo, G.
  3. Cancer Research. 2010, Sep 1; 70(17): 6837-6848.
  1. 10.   The CNK1 scaffold binds cytohesins and promotes insulin pathway signaling
  2. Lim, J.; Zhou, M.; Veenstra, T. D.; Morrison, D. K.
  3. Genes & Development. 2010, Jul; 24(14): 1496-1506.
  1. 11.   Synthesis, Antitubulin, and Antiproliferative SAR of Analogues of 2-Methoxyestradiol-3,17-O,O-bis-sulfamate
  2. Jourdan, F.; Leese, M. P.; Dohle, W.; Hamel, E.; Ferrandis, E.; Newman, S. P.; Purohit, A.; Reed, M. J.; Potter, B. V. L.
  3. Journal of Medicinal Chemistry. 2010, Apr; 53(7): 2942-2951.
  1. 12.   Mutational Analysis of Threonine 402 Adjacent to the GXXXG Dimerization Motif in Transmembrane Segment 1 of ABCG2
  2. Polgar, O.; Ierano, C.; Tamaki, A.; Stanley, B.; Ward, Y.; Xia, D.; Tarasova, N.; Robey, R. W.; Bates, S. E.
  3. Biochemistry. 2010, Mar; 49(10): 2235-2245.
  1. 13.   Survivin Is Not Induced by Novel Taxanes
  2. Sharifi, N.; Qi, J.; Bane, S.; Sharma, S.; Li, R.; Robey, R.; Figg, W. D.; Farrar, W. L.; Kingston, D. G. I.
  3. Molecular Pharmaceutics. 2010, Nov-Dec; 7(6): 2216-2223.
  1. 14.   Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
  2. Puri, A.; Loomis, K.; Smith, B.; Lee, J. H.; Yavlovich, A.; Heldman, E.; Blumenthal, R.
  3. Critical Reviews in Therapeutic Drug Carrier Systems. 2009 26(6): 523-580.
  1. 15.   Effect of Tumor Necrosis Factor-alpha on Estrogen Metabolism and Endometrial Cells: Potential Physiological and Pathological Relevance
  2. Salama, S. A.; Kamel, M. W.; Diaz-Arrastia, C. R.; Xu, X.; Veenstra, T. D.; Salih, S.; Botting, S. K.; Kumar, R.
  3. Journal of Clinical Endocrinology & Metabolism. 2009 94(1): 285-293.
  1. 16.   Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton
  2. Barkan, D.; Kleinman, H.; Simmons, J. L.; Asmussen, H.; Kamaraju, A. K.; Hoenorhoff, M. J.; Liu, Z. Y.; Costes, S. V.; Cho, E. H.; Lockett, S.; Khanna, C.; Chambers, A. F.; Green, J. E.
  3. Cancer Research. 2008 68(15): 6241-6250.
  1. 17.   Targeting the Activator Protein 1 Transcription Factor for the Prevention of Estrogen Receptor-Negative Mammary Tumors
  2. Shen, Q.; Uray, I. P.; Li, Y. X.; Zhang, Y.; Hill, J.; Xu, X. C.; Young, M. R.; Gunther, E. J.; Hilsenbeck, S. G.; Colburn, N. H.; Chodosh, L. A.; Brown, P. H.
  3. Cancer Prevention Research. 2008 1(1): 45-55.
  1. 18.   Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for BrcaI
  2. Wright, M. H.; Robles, A. I.; Herschkowitz, J. I.; Hollingshead, M. G.; Anver, M. R.; Perou, C. M.; Varticovski, L.
  3. Molecular Cancer. 2008 7(29): 1-12.
  1. 19.   Targeting to the endoplasmic reticulum improves the folding of recombinant human telomerase reverse transcriptase
  2. Wu, C. K.; Gousset, K.; Hughes, S. H.
  3. Protein Expression and Purification. 2007, Nov; 56(1): 8-19.
  1. 20.   Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1
  2. Li, P.; Jiang, S.; Lee, S. L.; Lin, C. Y.; Johnson, M. D.; Dickson, R. B.; Michejda, C. J.; Roller, P. P.
  3. Journal of Medicinal Chemistry. 2007, Nov; 50(24): 5976-5983.
  1. 21.   Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma
  2. Yi, L.; Zhou, Z. H.; Ping, Y. F.; Chen, J. H.; Yao, X. H.; Feng, H.; Lu, J. Y.; Wang, J. M.; Bian, X. W.
  3. Modern Pathology. 2007, Oct; 20(10): 1061-1068.
  1. 22.   15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain
  2. Kim, H. J.; Kim, J. Y.; Meng, Z. J.; Wang, L. H.; Liu, F.; Conrads, T. P.; Burke, T. R.; Veenstra, T. D.; Farrar, W. L.
  3. Cancer Research. 2007, Mar; 67(6): 2595-2602.
  1. 23.   Structure-based design of potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimics
  2. Jiang, S.; Li, P.; Peach, M. L.; Bindu, L.; Worthy, K. W.; Fisher, R. J.; Burke, T. R.; Nicklaus, M.; Roller, P. P.
  3. Biochemical and Biophysical Research Communications. 2006, Oct; 349(2): 497-503.
  1. 24.   Marine pharmacology in 2003-2004: Anti-tumour and cytotoxic compounds
  2. Mayer, A. M. S.; Gustafson, K. R.
  3. European Journal of Cancer. 2006, Sep; 42(14): 2241-2270.
  1. 25.   E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells
  2. Mani, A.; Oh, A. S.; Bowden, E. T.; Lahusen, T.; Lorick, K. L.; Weissman, A. M.; Schlegel, R.; Wellstein, A.; Riegel, A. T.
  3. Cancer Research. 2006, Sep; 66(17): 8680-8686.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel